Skip to main content
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · ETON ISIN · US29772L1089 US Manufacturing
Open in API
Filings indexed 358 across all filing types
Latest filing 2020-07-31 Regulatory Filings
Country US United States of America
Listing US ETON

About Eton Pharmaceuticals, Inc.

https://etonpharma.com/

Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. The company's strategy involves sourcing, acquiring, and developing therapies to serve small, underserved patient populations. Eton manages the complete drug development lifecycle, from navigating clinical trials and the regulatory approval process to bringing the final products to market. It actively seeks meaningful therapies from a global network of partners to build a diversified portfolio of treatments.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The text describes a lock-up agreement related to the company's common stock and the filing of a Registration Statement on Form S-3. There is no detailed financial data or comprehensive report content, but rather an announcement of a specific event. The document length is 3709 characters, which is relatively short and consistent with an 8-K filing. According to the classification rules, such filings are best categorized under Regulatory Filings (RNS) as they do not fit into other specific report categories like Annual Report or Earnings Release.
2020-07-31 English
Regulatory Filings 2020
Regulatory Filings Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC by Eton Pharmaceuticals, Inc. It is a registration statement under the Securities Act of 1933 for the resale of common stock by a selling stockholder. The document includes details about the securities being registered, the registration fee, and legal disclaimers. It is not a financial report, earnings release, or management discussion. It is a regulatory filing related to securities registration and offering, not a report or announcement of voting results, capital changes, or other categories. Therefore, it fits best under Regulatory Filings (RNS). The document length is 15,000 characters, indicating it is a full filing, not a brief announcement or certification.
2020-07-31 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text includes a press release about submitting a New Drug Application to the FDA, attached as an exhibit. There are no financial statements or detailed financial data included. The document is short (3134 characters) and primarily serves as an announcement of an event rather than a detailed financial or management report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2020-07-30 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text mentions the submission of a New Drug Application and includes a press release as an exhibit. The document is short (3366 characters) and primarily serves as an announcement of an event rather than a detailed financial report or other specific filing type. It does not contain financial statements or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2020-07-27 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated June 9, 2020, by Eton Pharmaceuticals, Inc. The content focuses on the submission of matters to a vote of security holders at the 2020 Annual Meeting, including election of directors and ratification of the appointment of the independent registered public accounting firm. The document provides detailed voting results for these proposals. This matches the description of a Declaration of Voting Results & Voting Rights Announcements (DVA) filing, which reports official results from shareholder votes at general meetings. The document length is under 5,000 characters and contains specific voting results, not a full annual report or other financial data. Therefore, the correct classification is DVA.
2020-06-10 English
Regulatory Filings 2020
Regulatory Filings Classification · 60% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, form names, fiscal period dates, or document titles that can be analyzed. There is no indication of the document type or any specific filing category. Given the lack of identifiable information and the fallback rule, the document should be classified as a Regulatory Filing (RNS). The confidence is moderate due to the inability to extract meaningful content.
2020-05-27 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.